Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
Klinik Hietzing · Medical University of Vienna · +6 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,398
total citations
- FWCI
- 79.17
- Percentile
- 100%
- References
- 49
Citations per year
Authors
8Topics & keywords
Topics
Keywords
- Tocilizumab
- Medicine
- Rheumatoid arthritis
- Placebo
- Internal medicine
- Clinical endpoint
- Rheumatology
- Methotrexate
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.